Mounjaro 2.5mg to 5mg: the first dose increase explained

The biggest myth: 'nothing is happening at 2.5mg, so the medicine isn't working'

This is the question our prescribers hear most weeks from people who have just finished their first Mounjaro pen and feel frustrated. The assumption is that 2.5mg should already be producing the weight loss seen in trial headlines. It should not, and expecting it to misunderstands what the starting pen is for.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only licensed weight-loss medicine in the UK that activates both pathways simultaneously. That potency is precisely why treatment opens at a low, deliberately sub-therapeutic dose. Jumping straight to 5mg or higher produces significantly more nausea, vomiting, and the kind of early discontinuation that undermines the whole course. The 2.5mg pen is not a gentle taster of what is to come; it is a clinical tool for keeping you on treatment long enough for treatment to work.

The trial evidence backs this up. In SURMOUNT-1, average weight reduction at 15mg was around 20–21% over 72 weeks, figures reported in the New England Journal of Medicine. Those results belong to the full titration sequence, not to any single dose taken in isolation. Weight change at mounjaro 2.5 mg, across just four weeks, tells you very little about your long-term trajectory.

If side effects at 2.5mg were minimal and your appetite has begun to feel subtly different, that is a reasonable sign the medicine is doing its preparatory work. The therapeutic chapter begins at 5mg.

What changes when you step up, and what to watch for

The move from 2.5mg to 5mg doubles the dose, and for most people that produces a noticeable increase in appetite suppression within the first week or two. Gastric emptying slows further; portion sizes that felt normal often feel like too much. That shift is the mechanism working as intended.

It can also bring a brief return of gastrointestinal side effects. Nausea, loose stools, or a general unsettled feeling in the stomach are common after any dose increase, and if you want a closer look at how that transition typically unfolds, our page on moving from mounjaro 2.5 mg to 5mg covers what most people experience. These effects typically settle within seven to fourteen days as your body adjusts to the new level. Eating smaller meals, staying well hydrated, and avoiding rich or fatty food in the days immediately after the step-up helps considerably. The NHS tirzepatide patient information page covers this profile clearly.

A smaller number of people experience more persistent symptoms, and that is exactly the conversation to have with your prescriber. Titration is not a rigid schedule; it is a clinical judgement. Staying at 2.5mg for a second four-week period is a legitimate option if your body needs it. Nobody should feel pressured to increase before they are ready.

Injection technique and site rotation also matter more as the dose increases. If you are unsure about the volume you are injecting, our guidance on the 2.5 ml mounjaro pen explains how the fill and delivery work in practice. Rotating between the abdomen, thigh, and upper arm, and avoiding injecting into the same spot consecutively, reduces localised discomfort and helps absorption stay consistent across the course.

Cost and access: what the step-up means in practice

One thing worth understanding early is that Mounjaro is supplied as a single pen per four-week period, with each pen containing four weekly doses at the stated strength. When you move from 2.5mg to 5mg, you move to a different pen, not a higher fill of the same one. That has practical implications for cost, since the price per pen varies by dose, and our page comparing mounjaro 2.5 vs 5 sets out the differences in both price and clinical profile so you know what to expect.

If you are thinking about the cost side of tirzepatide treatment, our guide to Mounjaro pricing in the UK explains what private prescription prices typically cover and what to look out for. Private treatment through a regulated pharmacy means no waiting list, but it does mean paying for each pen. At nume (sorry, at nume) one transparent price covers consultation, prescription, and free tracked delivery; there are no subscription commitments and every repeat order is reviewed by a prescriber before dispatch.

For people wondering whether they qualify medically, the licensed eligibility threshold is a BMI of 30 or above, or 27 or above with at least one weight-related condition. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The prescriber looks at the full picture, not just the number.

When your prescriber reviews the increase

At nume, no dose increase goes out without a clinical re-review. That means when you order your 5mg pen, a prescriber checks your progress, any side effects reported, and whether the step-up is appropriate for you, including confirming details such as the mounjaro 2.5 g content of your current pen before approving the move to the next strength. It is the same process whether it is your second pen or your tenth.

Orders placed by noon on a weekday are reviewed the same day and, once approved, dispatched for free next-working-day tracked delivery via DPD, plain, unbranded packaging. If you have questions about the process before you begin, the FAQs page covers the most common ones. For anything more specific to your situation, our prescribers are reachable seven days a week through the contact page.

Titration works best when you feel supported through it. If you are ready to begin or to discuss where you are in your course, you can speak to our prescribers via a free consultation, no obligation, reviewed the same day.